Department of Medicine 3 – Rheumatology and Immunology

Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials (2016) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Conference contribution Novel Mechanism Mediated By the IL-23/Th17 Axis Contributing to Auto-Immune Arthritis (2016) Pfeifle R, Rothe T, Ipseiz N, Culemann S, Harre U, Krönke G, Schett G Conference contribution OBSERVATIONAL STUDY OF OUTCOME IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS TREATED WITH IMMUNOSUPPRESSIVE THERAPIES (ESOS STUDY) (2016) Herrick AL, Pan X, Peytrignet S, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution Periarticular Bone Loss in Arthritis Is Induced By Autoantibodies Against Citrullinated Vimentin (2016) Engdahl C, Bang H, Dietel K, Lang S, Harre U, Schett G Conference contribution INFLUENCE OF SEROTONIN (5-HT) RECEPTOR TYPE 2 ANTAGONISTS ON THE DEVELOPMENT OF TRANSPLANT VASCULOPATHY IN A MODEL OF MURINE AORTIC TRANSPLANTATION (2016) Gocht A, Distler J, Ensminger S, Spriewald B, Ramsperger-Gleixner M, Weyand M, Heim C Conference contribution High Fat Diet Alleviates Antigen-Induced Arthritis Severity in Male Mice By Enhancing Both Treg and B10 Cells (2016) Luo Y, Engdahl C, Yi Zaho , Liu Y, Schett G, Bozec A Conference contribution Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2016) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Fibroblast Growth Factor 9/Fibroblast Growth Factor Receptor 3 Signaling Is Upstream of Several Profibrotic Pathways and Induces Fibroblast Activation and Tissue Fibrosis in SSc (2016) Mallano T, Distler A, Dees C, Huang J, Distler O, Schett G, Distler J, Chakraborty D Conference contribution INTER SPA: SENSITIVITY AND SPECIFITY OF AUTOANTIBODIES AGAINST CD74 IN EARLY AXIAL SPONDYLOARTHRITIS (2016) Riechers E, Baerlecken NT, Baraliakos X, Bakhsh KAM, Aries PM, Bannert B, Becker K, et al. Conference contribution FRA2 IS PLAYING A KEY ROLE IN THE CONTROL OF TREG DEVELOPMENT AND AUTOIMMUNITY (2016) Renoux F, Stellato M, Pachera E, Impellizzieri D, Dees C, Distler J, Kania G, et al. Conference contribution